Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedA revision tag on the page updates to v3.6.5, replacing the previous v3.6.4. This signals a backend/template update rather than a substantive change to study details or participant information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a small behind-the-scenes update to the site. This does not alter the study details or visible content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page content. This appears to be a minor, administrative update rather than a substantive change to study information.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates an updated version of the page text and metadata.SummaryDifference0.0%

- Check70 days agoChange DetectedRecruitment status now states that enrollment is closed. The update also adds help and navigation sections, refines a label, and updates the revision tag to v3.6.0.SummaryDifference0.2%

- Check77 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor version update to the page. It does not modify study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.